Home NYT Moderna and Pfizer-BioNTech reconsider their battle plans after a variant proves more challenging. by Rudro khan - January 26, 2021 0 By BY DENISE GRADY from NYT World https://ift.tt/39maxRf Tags NYT Facebook Twitter